Holen Sie sich die Stockscreener-App
161.82
1.11%
-2.115
Schlusskurs vom Vortag:
$163.94
Offen:
$163.99
24-Stunden-Volumen:
810.65K
Relative Volume:
0.33
Marktkapitalisierung:
$34.17B
Einnahmen:
$398.11M
Nettoeinkommen (Verlust:
$-1.03B
KGV:
-28.37
EPS:
-5.7032
Netto-Cashflow:
$-868.57M
1W Leistung:
-0.13%
1M Leistung:
+11.09%
6M Leistung:
+128.23%
1J Leistung:
+115.92%
1-Tages-Spanne:
$161.41
$164.34
1-Wochen-Bereich:
$159.78
$166.44
52-Wochen-Spanne:
$60.40
$166.44
Insmed Inc Stock (INSM) Company Profile
Firmenname
Insmed Inc
Sektor
Branche
Telefon
908-977-9900
Adresse
700 US HIGHWAY 202/206, BRIDGEWATER, NJ
Vergleichen Sie INSM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
INSM
Insmed Inc
|
161.65 | 34.65B | 398.11M | -1.03B | -868.57M | -5.7032 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.58 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
468.40 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.96 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
804.75 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.91 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Insmed Inc Stock (INSM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-20 | Eingeleitet | William Blair | Outperform |
| 2025-08-13 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-05-13 | Eingeleitet | Jefferies | Buy |
| 2025-02-25 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2024-04-23 | Eingeleitet | Truist | Buy |
| 2024-02-15 | Eingeleitet | Wolfe Research | Outperform |
| 2023-12-08 | Eingeleitet | Wells Fargo | Overweight |
| 2023-11-20 | Fortgesetzt | JP Morgan | Overweight |
| 2023-07-26 | Eingeleitet | Guggenheim | Buy |
| 2022-12-09 | Eingeleitet | Mizuho | Buy |
| 2022-12-07 | Eingeleitet | Barclays | Overweight |
| 2022-11-18 | Eingeleitet | BofA Securities | Buy |
| 2022-04-27 | Eingeleitet | Goldman | Buy |
| 2021-12-06 | Eingeleitet | JP Morgan | Overweight |
| 2021-10-19 | Fortgesetzt | Monness Crespi & Hardt | Buy |
| 2021-10-19 | Fortgesetzt | Morgan Stanley | Overweight |
| 2021-10-08 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2021-04-26 | Fortgesetzt | Credit Suisse | Outperform |
| 2020-12-17 | Eingeleitet | Berenberg | Buy |
| 2020-10-12 | Fortgesetzt | Stifel | Buy |
| 2019-09-03 | Eingeleitet | Goldman | Buy |
| 2019-04-09 | Bestätigt | H.C. Wainwright | Buy |
| 2019-02-15 | Hochstufung | JMP Securities | Mkt Perform → Mkt Outperform |
| 2019-01-17 | Hochstufung | Goldman | Neutral → Buy |
| 2019-01-02 | Eingeleitet | Canaccord Genuity | Buy |
| 2018-08-06 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
| 2018-07-23 | Eingeleitet | Goldman | Neutral |
| 2018-04-23 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2018-03-21 | Eingeleitet | Morgan Stanley | Overweight |
| 2018-01-18 | Eingeleitet | Credit Suisse | Neutral |
| 2017-09-05 | Bestätigt | Evercore ISI | Outperform |
| 2017-08-17 | Eingeleitet | Evercore ISI | Outperform |
| 2017-07-11 | Eingeleitet | Robert W. Baird | Outperform |
| 2016-03-15 | Eingeleitet | Stifel | Buy |
| 2015-11-09 | Herabstufung | UBS | Buy → Neutral |
| 2015-10-06 | Bestätigt | H.C. Wainwright | Buy |
| 2015-06-09 | Eingeleitet | Citigroup | Neutral |
| 2014-03-26 | Bestätigt | HC Wainwright | Buy |
Alle ansehen
Insmed Inc Aktie (INSM) Neueste Nachrichten
UBS Raises Price Target for Insmed (INSM) Following Consistent " - GuruFocus
UBS Adjusts Insmed Price Target to $194 From $140, Maintains Buy Rating - MarketScreener
Key metrics from Insmed Incorporated’s quarterly dataJuly 2025 Weekly Recap & Free Safe Entry Trade Signal Reports - newser.com
What dividend safety score for Insmed Incorporated stockQuarterly Earnings Summary & Fast Gain Stock Trading Tips - newser.com
How Insmed Incorporated stock reacts to Fed rate cutsJuly 2025 EndofMonth & High Accuracy Swing Entry Alerts - newser.com
Can Insmed Incorporated hit a new high this month2025 Year in Review & Stepwise Trade Signal Guides - newser.com
Insmed Incorporated stock prediction for this weekPortfolio Risk Summary & Growth Focused Entry Point Reports - newser.com
Can Insmed Incorporated stock maintain operating marginsJuly 2025 Reactions & High Accuracy Trade Signal Alerts - newser.com
What institutional flow reveals about Insmed IncorporatedJuly 2025 PreEarnings & Intraday High Probability Setup Alerts - newser.com
Is Insmed Incorporated trending in predictive chart modelsPortfolio Performance Report & High Return Trade Opportunity Guides - newser.com
Is a relief rally coming for Insmed Incorporated holders2025 Short Interest & Capital Efficiency Focused Ideas - newser.com
What indicators show strength in Insmed IncorporatedPortfolio Gains Summary & Real-Time Market Trend Scan - newser.com
How to build a custom watchlist for Insmed IncorporatedPortfolio Risk Summary & Short-Term Swing Trade Alerts - newser.com
Real time alert setup for Insmed Incorporated performance2025 Key Lessons & Weekly Top Gainers Alerts - newser.com
Reversal indicators forming on Insmed Incorporated stockJuly 2025 Drop Watch & Fast Entry High Yield Stock Tips - newser.com
How Insmed Incorporated (IM8N) stock performs during market turbulenceQuarterly Earnings Report & Safe Capital Growth Stock Tips - newser.com
Why Biotech’s Rally Can Last This Time - The Wall Street Journal
Maryland State Retirement & Pension System Invests $873,000 in Insmed, Inc. $INSM - MarketBeat
Aberdeen Group plc Decreases Stock Position in Insmed, Inc. $INSM - MarketBeat
Oak Ridge Investments LLC Sells 7,757 Shares of Insmed, Inc. $INSM - MarketBeat
Insmed, Inc. $INSM Holdings Raised by KLP Kapitalforvaltning AS - MarketBeat
What moving averages say about Insmed IncorporatedJuly 2025 Summary & Daily Stock Trend Reports - newser.com
How buyback programs support Insmed Incorporated (IM8N) stockMarket Activity Recap & Stepwise Entry and Exit Trade Signals - newser.com
Real time breakdown of Insmed Incorporated stock performanceJuly 2025 Market Mood & High Yield Stock Recommendations - newser.com
What does recent volatility data suggest for Insmed Incorporated2025 Price Targets & Reliable Breakout Stock Forecasts - newser.com
Insmed, Inc. Hits New 52-Week High of $163.22, Up 170% Yearly - Markets Mojo
Insmed stock hits 52-week high at 164.04 USD - Investing.com India
Insmed stock hits 52-week high at 164.04 USD By Investing.com - Investing.com Australia
How to interpret RSI for Insmed Incorporated stock2025 Support & Resistance & Reliable Breakout Forecasts - newser.com
Weiss Ratings Reaffirms "Sell (D-)" Rating for Insmed (NASDAQ:INSM) - MarketBeat
Insmed, Inc. (NASDAQ:INSM) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Insmed, Inc. Hits New 52-Week High of $160.62, Up 164% Yearly - Markets Mojo
Insmed, Inc. Hits New 52-Week High of $162.44, Up 171% Year-Over-Year - Markets Mojo
Pulmonary Arterial Hypertension Market Positioned for Accelerated Development Through 2034, DelveInsight Finds | Merck, Janssen Pharma, Aerovate Therapeutics, Novartis, Insmed Inc, Chugai Pharma - The Globe and Mail
This ‘Strong Buy’ Stock Is Trading at New 20-Year Highs - MSN
This ‘Strong Buy’ Stock Is Trading At New 20-Year Highs - Barchart.com
RBC Lifts Price Target on Insmed to $139 From $138, Keeps Outperform Rating - MarketScreener
Insmed (NASDAQ:INSM) Sets New 12-Month HighShould You Buy? - MarketBeat
Insmed, Inc. Hits New 52-Week High of $158.19, Up 162% - Markets Mojo
Is Insmed Incorporated a good long term investmentMorning Star Patterns & Free Popular Stock Picks Selection - earlytimes.in
111 Capital Makes New Investment in Insmed, Inc. $INSM - MarketBeat
Chung Wu Investment Group LLC Takes $173,000 Position in Insmed, Inc. $INSM - MarketBeat
Is Insmed Incorporated (IM8N) stock bottoming after sell offPortfolio Gains Summary & Daily Chart Pattern Signals - newser.com
How Analysts Are Rethinking Insmed After Brinsupri’s Approval and New Revenue Projections - Yahoo Finance
A Quick Look at Today's Ratings for Insmed(INSM.US), With a Forecast Between $102 to $124 - 富途牛牛
Goldman Sachs Remains a Buy on Insmed (INSM) - The Globe and Mail
Goldman Sachs Maintains Insmed (INSM) Buy Recommendation - Nasdaq
Finanzdaten der Insmed Inc-Aktie (INSM)
Umsatz
Nettogewinn
Free Cashflow
ENV
Insmed Inc-Aktie (INSM) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Schaeffer Orlov S Nicole | Chief People Strategy Officer |
Sep 12 '25 |
Sale |
145.45 |
76,520 |
11,129,927 |
36,461 |
| SHAROKY MELVIN MD | Director |
Sep 12 '25 |
Sale |
145.39 |
10,000 |
1,453,900 |
262,675 |
1.84%
0.37%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):